Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for HIV-1 Reservoir Reactivation
NCT06282783Phase 2Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiramate in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Erasmus MC. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
topiramate
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT06282783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06282783.